earnings
confidence high
sentiment negative
materiality 0.80
USANA Q4 net sales -3% to $214M; net earnings -73% to $4.5M; FY2025 guidance includes Hiya
USANA HEALTH SCIENCES INC
2023-FY EPS reported
$2.19
revenue$854,503,000
- Q4 net sales $214M (-3% YoY); net earnings $4.5M (-73%); diluted EPS $0.23 (-74%).
- FY2024 net sales $855M (-7% YoY); net earnings $42M (-34%); diluted EPS $2.19.
- Active customers 454K (-6% YoY); Americas & Europe net sales +1% YoY, Asia Pacific -6%.
- Closed acquisition of 78.8% of Hiya on Dec 23, 2024; contributed ~$2M in Q4 sales.
- FY2025 outlook: net sales $920M–$1.0B; diluted EPS $1.50–$2.20; adjusted diluted EPS $2.35–$3.00.